George Morrow
Director/Board Member at ALIGN TECHNOLOGY, INC.
Net worth: 2 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Bradway | M | 61 | 18 years | |
| Gary Lyons | M | 73 |
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | 31 years |
| Kevin Gorman | M | 66 | 32 years | |
| Stephen Sherwin | M | 75 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | 25 years |
| William Rastetter | M | 75 | 14 years | |
| C. Larkin | M | 75 | 20 years | |
| Joseph Hogan | M | 66 | 9 years | |
| John Morici | M | 57 | 8 years | |
| Anne Myong | F | 56 | 5 years | |
| Sreelakshmi Kolli | F | 49 | 21 years | |
| Johanna Mercier | F | 54 | 3 years | |
| David Reese | M | 61 | 19 years | |
| Chester Koczynski | M | - |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 12 years |
| Kevin Dallas | M | 60 | 6 years | |
| Dan Troy | M | 64 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 12 years |
| Caroline Litchfield | F | 55 | 34 years | |
| Bill Wilson | M | - | 28 years | |
| Emory Wright | M | 54 | 24 years | |
| Esteban Santos | M | 56 | 17 years | |
| Susan Siegel | F | 63 | 7 years | |
| Andrea Saia | F | 66 | 11 years | |
| Ronald Sugar | M | 75 | 14 years | |
| Darin Lippoldt | M | 58 | 10 years | |
| Robert Eckert | M | 69 | 21 years | |
| Christine Poon | F | 71 | 1 years | |
| Richard Pops | M | 62 | 26 years | |
| Dimitri Grigoriadis | M | 65 | 31 years | |
| Joseph Lacob | M | 68 | 27 years | |
| Leslie Norwalk | F | 58 | 26 years | |
| Shalini Sharp | F | 49 | 4 years | |
| Matthew Busch | M | 50 | 20 years | |
| Zelko Relic | M | 59 | 11 years | |
| Kyle Gano | M | 50 | 13 years | |
| Julie Cooke | F | 57 | 7 years | |
| David Redfern | M | 57 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 12 years |
| Adrian Rawcliffe | M | 52 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 12 years |
| Raj Pudipeddi | M | 51 | 3 years | |
| Mojdeh Poul | F | 61 | 1 years | |
| Kevin Conroy | M | 58 | 1 years | |
| Mike Zahigian | M | - | 23 years | |
| David Boyer | M | 44 | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kenneth Frazier | M | 69 | 30 years | |
| Richard Kogan | M | 81 | 21 years | |
| Roger E. George | M | 58 | 17 years | |
| Vijay Samant | M | 77 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | 19 years |
| Frank Herringer | M | 81 | 15 years | |
| R. Gordon Douglas | M | 89 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | 28 years |
| Eric Loumeau | M | 61 | 3 years | |
| Michael Kelly | M | 67 | 14 years | |
| Pamela Wapnick | F | 58 | 9 years | |
| David W. Beier | M | 75 | 10 years | |
| Dennis Fenton | M | 72 | 27 years | |
| Marc M. P. de Garidel | M | 66 | 15 years | |
| David-Alexandre Gros | M | 51 | - | |
| Gregory L. Tewalt | M | - | 18 years | |
| Andrew Sklawer | M | 41 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | - |
| Paul Eisenberg | M | - | 14 years | |
| Kathryn Falberg | F | 63 | 6 years | |
| Thomas Prescott | M | 68 | 19 years | |
| Joseph A. Mollica | M | 83 | 20 years | |
| Steven A. Burd | M | 74 | 21 years | |
| Deirdre Connelly | F | 63 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 3 years |
| Robert Alexander Ingram | M | 81 |
Glaxo Wellcome, Inc.
| 2 years |
| Timothy Proctor | M | 74 |
Glaxo Wellcome, Inc.
| 6 years |
| Brian H. Dovey | M | 83 | 5 years | |
| H. Watkins | M | 71 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 8 years |
| Robert Gordon | M | 72 | 16 years | |
| Raphael S. Pascaud | M | 52 | 9 years | |
| David F. Bond | M | 70 | 18 years | |
| Thomas Zindrick | M | 65 | 8 years | |
| Reginald Hardy | M | 64 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | - |
| Puco Christopher | M | 63 | 13 years | |
| Craig Shepherd | M | - | 7 years | |
| Vasant Prakash Gandhi | M | - | 5 years | |
| Maxine Gowen | M | 66 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 4 years |
| Randal Golden | M | 63 | 5 years | |
| David L. White | M | 68 | 3 years | |
| John Moriarty | M | 56 | 6 years | |
| Preston Klassen | M | 55 | 7 years | |
| Cynthia Flowers | F | 64 | 5 years | |
| Timothy Mack | M | - | 4 years | |
| Kenneth Bartizal | M | 72 | 20 years | |
| Robert C. Merton | M | 79 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | 17 years |
| Patricia Cary Sueltz | F | 71 | 2 years | |
| David C. Nagel | M | 78 | 7 years | |
| John J Horan | M | - | 6 years | |
| Mohanbir Singh Gyani | M | 71 | 11 years | |
| Larree Renda | F | 66 | 40 years | |
| Kenneth B. Arola | M | 68 | 8 years | |
| Robert Miller | M | 79 | - | |
| Larry Smith | M | 63 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | 16 years |
| John McKearn | M | 70 | 5 years | |
| Barry A. Labinger | M | 60 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 7 years |
| Warren S. Thaler | M | 61 | 19 years | |
| Marino Carol | F | - | 8 years | |
| Theodore Schroeder | M | 69 | 8 years | |
| Peter Bisgaard | M | 50 | 5 years | |
| Colin Goddard | M | 64 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 2 years |
| Bob H. Campbell | M | 86 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | 10 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- George Morrow
- Personal Network
